FOLH1 and posterior cortical atrophy: Metastatic PCa can be hormone-sensitive and castration-resistant where the PCa cells are refractory to androgen deprivation therapy and there is disease progression even at castrate levels of testosterone, and PSMA uptake (PSMA expression) is decreased in mCRPC as compared to hormone sensitive disease [51].